Free Cancer Research Webinar
The Fundamental Hallmark of Cancer
From discovery 44 years ago to the present excitement
Dr. Robert M. Hoffman
Enago in collaboration with AntiCancer, Inc.—the world’s leading preclinical cancer contract research organization—is glad to announce an advanced session on cancer research studies. Dr. Robert M. Hoffman (President, Chairman of Board and CEO, AntiCancer, Inc.), a veteran scientist who discovered the methionine addiction of cancer (Hoffman Effect), will describe the mechanism of the methionine addiction and how this fundamental hallmark of all cancers can be targeted therapeutically.
With 55+ years of significant contribution to science, Dr. Hoffman has conducted pioneering research studies to provide treatment for cancer. His session will focus on discussing the following key topics related to methionine addiction:
What is the Hoffman effect?
Everything about methionine addiction and its importance in cancer
Role of methylation and transmethylation reactions
Which is the most powerful form of PET imaging in cancer?
Cancer treatment using methionine restriction
WHO SHOULD ATTEND THIS SESSION?
Cancer Researchers and Scientists
Doctors and Clinicians
Health Care Professionals
Oncology Societies and Cancer Institute
Date of Input: 09/12/2020 | Updated: 09/12/2020 | engkuliyana
Office of The Deputy Vice Chancellor (Research & Innovation)
Universiti Putra Malaysia
43400 UPM Serdang, Selangor